Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron

Runkai Yin1, Kelly X Huang1, Lina A Huang1

  • 1Department of Translational Research & Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

PubMed

Insights

Researchers reviewed G-protein coupled receptor 44 (GPR44) antagonists to develop fluorine-18 labeled PET tracers. These tracers can help visualize inflammation and cancer, aiding targeted therapy development.

Area of Science:

  • Oncology
  • Radiochemistry
  • Pharmacology

Background:

  • Growing evidence links G-protein coupled receptor 44 (GPR44) to inflammation and cancer.
  • The precise role of GPR44 in tumor biology requires further elucidation.
  • There is a need for non-invasive imaging tools to study GPR44's role in vivo.

Purpose of the Study:

  • To evaluate indole-based and cyclopentenyl-indole-based GPR44 antagonists for developing fluorine-18 labeled PET tracers.
  • To guide the development of PET tracers for visualizing inflammatory processes.
  • To identify compounds suitable for in vivo imaging of inflammation and cancer.

Main Methods:

  • Systematic review of published GPR44 antagonists (2000-present).
  • Focus on indole and cyclopentenyl-indole analogues containing fluorine.
  • Evaluation of binding affinity, selectivity, and pharmacokinetic/metabolic profiles.

Main Results:

  • Identified 26 GPR44 analogues with favorable to strong binding properties.
  • Selected analogues contain a fluorine nuclide suitable for radiolabeling.
  • Characterization data provides a basis for PET tracer development.

Conclusions:

  • GPR44 analogues show significant potential for developing PET tracers.
  • Fluorine-18 labeled GPR44 tracers can aid in studying inflammation and cancer.
  • This research can guide the development of targeted clinical therapies for cancer.